324 related articles for article (PubMed ID: 33418496)
1. The RNA methyltransferase NSUN6 suppresses pancreatic cancer development by regulating cell proliferation.
Yang R; Liang X; Wang H; Guo M; Shen H; Shi Y; Liu Q; Sun Y; Yang L; Zhan M
EBioMedicine; 2021 Jan; 63():103195. PubMed ID: 33418496
[TBL] [Abstract][Full Text] [Related]
2. NSUN6 Regulates NM23-H1 Expression in an m5C Manner to Affect Epithelial-Mesenchymal Transition in Lung Cancer.
Lu Z; Liu B; Kong D; Zhou X; Pei D; Liu D
Med Princ Pract; 2024; 33(1):56-65. PubMed ID: 38029727
[TBL] [Abstract][Full Text] [Related]
3. NSUN6 mediates 5-methylcytosine modification of METTL3 and promotes colon adenocarcinoma progression.
Cui Y; Lv P; Zhang C
J Biochem Mol Toxicol; 2024 Jun; 38(6):e23749. PubMed ID: 38800929
[TBL] [Abstract][Full Text] [Related]
4. Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma.
Cheng Y; Wang K; Geng L; Sun J; Xu W; Liu D; Gong S; Zhu Y
EBioMedicine; 2019 Feb; 40():382-393. PubMed ID: 30639415
[TBL] [Abstract][Full Text] [Related]
5. NSUN6 is a human RNA methyltransferase that catalyzes formation of m5C72 in specific tRNAs.
Haag S; Warda AS; Kretschmer J; Günnigmann MA; Höbartner C; Bohnsack MT
RNA; 2015 Sep; 21(9):1532-43. PubMed ID: 26160102
[TBL] [Abstract][Full Text] [Related]
6. Sequence-specific and Shape-selective RNA Recognition by the Human RNA 5-Methylcytosine Methyltransferase NSun6.
Long T; Li J; Li H; Zhou M; Zhou XL; Liu RJ; Wang ED
J Biol Chem; 2016 Nov; 291(46):24293-24303. PubMed ID: 27703015
[TBL] [Abstract][Full Text] [Related]
7. Sequence- and structure-specific cytosine-5 mRNA methylation by NSUN6.
Selmi T; Hussain S; Dietmann S; Heiß M; Borland K; Flad S; Carter JM; Dennison R; Huang YL; Kellner S; Bornelöv S; Frye M
Nucleic Acids Res; 2021 Jan; 49(2):1006-1022. PubMed ID: 33330931
[TBL] [Abstract][Full Text] [Related]
8. ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis.
Wang A; Dai H; Gong Y; Zhang C; Shu J; Luo Y; Jiang Y; Liu W; Bie P
J Exp Clin Cancer Res; 2019 Aug; 38(1):347. PubMed ID: 31395079
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the prognostic and oncologic values of ITGB superfamily members in pancreatic cancer.
Zhuang H; Zhou Z; Ma Z; Li Z; Liu C; Huang S; Zhang C; Hou B
J Cell Mol Med; 2020 Nov; 24(22):13481-13493. PubMed ID: 33073486
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA XLOC_000647 suppresses progression of pancreatic cancer and decreases epithelial-mesenchymal transition-induced cell invasion by down-regulating NLRP3.
Hu H; Wang Y; Ding X; He Y; Lu Z; Wu P; Tian L; Yuan H; Liu D; Shi G; Xia T; Yin J; Cai B; Miao Y; Jiang K
Mol Cancer; 2018 Jan; 17(1):18. PubMed ID: 29386037
[TBL] [Abstract][Full Text] [Related]
11. RNA m5C methylation orchestrates BLCA progression via macrophage reprogramming.
Yan D; Xie Y; Huang L; Zhang Y; Gu R; Xie H; Huang X; Luo H
J Cell Mol Med; 2023 Aug; 27(16):2398-2411. PubMed ID: 37408139
[TBL] [Abstract][Full Text] [Related]
12. Structural basis for substrate binding and catalytic mechanism of a human RNA:m5C methyltransferase NSun6.
Liu RJ; Long T; Li J; Li H; Wang ED
Nucleic Acids Res; 2017 Jun; 45(11):6684-6697. PubMed ID: 28531330
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA PXN-AS1 suppresses pancreatic cancer progression by acting as a competing endogenous RNA of miR-3064 to upregulate PIP4K2B expression.
Yan J; Jia Y; Chen H; Chen W; Zhou X
J Exp Clin Cancer Res; 2019 Sep; 38(1):390. PubMed ID: 31488171
[TBL] [Abstract][Full Text] [Related]
14. High calpain-1 expression predicts a poor clinical outcome and contributes to tumor progression in pancreatic cancer patients.
Yu LM; Zhu YS; Xu CZ; Zhou LL; Xue ZX; Cai ZZ
Clin Transl Oncol; 2019 Jul; 21(7):924-932. PubMed ID: 30565085
[TBL] [Abstract][Full Text] [Related]
15. Heat shock factor 1 inhibits the mitochondrial apoptosis pathway by regulating second mitochondria-derived activator of caspase to promote pancreatic tumorigenesis.
Liang W; Liao Y; Zhang J; Huang Q; Luo W; Yu J; Gong J; Zhou Y; Li X; Tang B; He S; Yang J
J Exp Clin Cancer Res; 2017 May; 36(1):64. PubMed ID: 28482903
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-195 Suppresses the Progression of Pancreatic Cancer by Targeting DCLK1.
Zhou B; Sun C; Hu X; Zhan H; Zou H; Feng Y; Qiu F; Zhang S; Wu L; Zhang B
Cell Physiol Biochem; 2017; 44(5):1867-1881. PubMed ID: 29224010
[TBL] [Abstract][Full Text] [Related]
17. miR-92b-3p acts as a tumor suppressor by targeting Gabra3 in pancreatic cancer.
Long M; Zhan M; Xu S; Yang R; Chen W; Zhang S; Shi Y; He Q; Mohan M; Liu Q; Wang J
Mol Cancer; 2017 Oct; 16(1):167. PubMed ID: 29078789
[TBL] [Abstract][Full Text] [Related]
18. Regulation of GLI Underlies a Role for BET Bromodomains in Pancreatic Cancer Growth and the Tumor Microenvironment.
Huang Y; Nahar S; Nakagawa A; Fernandez-Barrena MG; Mertz JA; Bryant BM; Adams CE; Mino-Kenudson M; Von Alt KN; Chang K; Conery AR; Hatton C; Sims RJ; Fernandez-Zapico ME; Wang X; Lillemoe KD; Fernández-Del Castillo C; Warshaw AL; Thayer SP; Liss AS
Clin Cancer Res; 2016 Aug; 22(16):4259-70. PubMed ID: 27169995
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Significance and Tumor Immune Microenvironment Heterogenicity of m5C RNA Methylation Regulators in Triple-Negative Breast Cancer.
Huang Z; Pan J; Wang H; Du X; Xu Y; Wang Z; Chen D
Front Cell Dev Biol; 2021; 9():657547. PubMed ID: 33928086
[TBL] [Abstract][Full Text] [Related]
20. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
